Fujifilm to accelerate the manufacturing of Avigan to treat COVID-19
By Akshay Kedari  Date: 2020-04-16

Fujifilm to accelerate the manufacturing of Avigan to treat COVID-19

Fujifilm, a renowned Japanese pharmaceutical company, has reportedly announced plans to boost the production of Avigan, an antiviral drug said to be a possible therapy for coronavirus. Avigan is primarily used to treat Influenza.

The company is aiming to provide this drug in large quantities in order to meet the nationwide growing need for antiviral drugs. The company hopes to produce hundreds of thousands of Avigan doses during the coming months.

The drug maker is currently increasing its production capacity in its Toyoma facility to accelerate the production rate. Since the company is planning large-scale production for Avigan, it has created strategic collaborations with international and domestic firms to provide the raw material for manufacturing Avigan and has also added capacity at its Mako Pure Chemical Co. unit to manufacture active pharmaceutical ingredients of the drug.

Since Fujifilm will now have its massive production in place, it is expecting to produce 100,000 Avigan treatments courses ready for use by July. This number of 3.5 times Avigan’s supply in March and the company has further plans to manufacture 300,000 regimens in place by September.

Japanese drug maker, last month, stated its intentions to accelerate the production of Avigan, after the news made a global impact. However, the company also made some clarifications about its use. The company particularly specified that the Influenza treatment drug has never been distributed in any market and that it is not available in any pharmacies and hospitals across Japan as well as overseas.

Avigan is an antiviral drug developed by the Toyama Chemical unit of Fujifilm and it received approval for sale back in 2014 to treat influenza. However, it was told that this drug can only be used when all other treatments turn out to be ineffective against a re-emerging or novel influenza virus.

While talking about this drug, Shinzo Abe, the Prime Minister of Japan stated that the government would soon initiate tests of Avigan in coronavirus patients in collaboration with other nations and simultaneously accelerate the production while aiming a faster approval for the drug.

Source credit: https://www.fiercepharma.com/manufacturing/fujifilm-speeds-production-potential-covid-19-therapy-avigan

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Moovaz acquires The Finder from Singapore Press Holdings (SPH)
Moovaz acquires The Finder from Singapore Press Holdings (SPH)
By Akshay Kedari

Singapore-based relocation services startup, Moovaz has successfully acquired the country’s longest-running publication for expats, The Finder, from Singapore Press Holdings (SPH). According to the agreement, SPH, which prints The Business Time...

Sirius Computer buys Advanced Systems Group to expand western presence
Sirius Computer buys Advanced Systems Group to expand western presence
By Akshay Kedari

Sirius Computer Solutions, Inc. which is a prominent national IT solutions integrator, has recently announced it has bought Advanced Systems Group, based in Denver. The purchase had been closed on May 31 and will help Sirius majorly expand its footpr...

SK Telecom launches TEAC applications to support 5G startups
SK Telecom launches TEAC applications to support 5G startups
By Akshay Kedari

SK Telecom, a South Korean telecommunications firm, has recently launched TEAC (TIP Ecosystem Acceleration Center) program applications to produce new and advanced growth drivers with the help of next-gen 5G edge services to aid businesses as they co...

SpaceX halts 1st astronaut launch due to stormy weather in Florida
SpaceX halts 1st astronaut launch due to stormy weather in Florida
By Akshay Kedari

SpaceX, an American aerospace and space transportation services provider, has reportedly halted its 1st U.S. astronaut launch into orbit from Florida in 9 years. This landmark moment for the company and NASA has recently been hindered by the stormy w...

UV Angel ties up with Smile One Services, launches new dental products
UV Angel ties up with Smile One Services, launches new dental products
By Akshay Kedari

UV Angel, a company renowned in the field of pathogen control technology, has recently announced that it has partnered with Smile One Services, which is dental service organization (DSO)  based in Michigan. Reportedly, the partnership has been i...